| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2003;125:290-300
© 2003 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease (ACD) |
From Providence Health System, Portland, Ore.
Received for publication Jan 28, 2002. Revisions requested April 1, 2002; revisions received July 10, 2002. Accepted for publication July 18, 2002. Address for reprints: Gary Grunkemeier, PhD, 9155 SW Barnes, No. 33, Portland, OR 97225 (E-mail: ggrunkemeier{at}providence.org).
Objectives: From the widely differing complication rates published for every heart valve, is it possible to determine a true rate for each valve and to compare the rates of two different valves? We investigated this question for the two most popular bileaflet valves.
Methods: Aortic valve data were abstracted from 14 St Jude Medical (St Jude Medical Inc, Minneapolis, Minn; 33,125 patient-y) and 11 Carbomedics (Sulzer Carbomedics Inc, Austin, Tex; 19,141 patient-y) series, and mitral valve data were abstracted from 11 St Jude Medical (21,553 patient-y) and 8 Carbomedics (8368 patient-y) series. Regression analysis was used to accommodate heterogeneity among rates with the same valve model, to estimate hazard ratios and 95% confidence intervals for the valve model effect, and to incorporate other series-level risk factors.
Results: Most of the complication rates with both valve models exhibited significant heterogeneity. For thromboembolism and bleeding, the relative risks for valve model were not significantly different from unity. Valve thrombosis rates exhibited less heterogeneity: the Carbomedics valve had a lower rate in the aortic position (hazard ratio 0.2, 95% confidence interval 0.1-0.6) and a higher rate in the mitral position (hazard ratio 1.9, 95% confidence interval 1.0-3.8).
Conclusions: Unlike simple weighted averages of valve complication rates, regression methods can incorporate heterogeneity related to center effects and allow for inclusion of other risk factors. Thromboembolism and bleeding rates were not significantly different with St Jude Medical and Carbomedics valves. Valve thrombosis appeared to differ between the two valves, but the absolute differences in rates were small. Because of the variability among rates with the same valve, statistical comparisons must be interpreted cautiously.
This article has been cited by other articles:
|
|
 |
|
  N. Oake MSc, A. Jennings MA, A. J. Forster MD MSc, D. Fergusson PhD, S. Doucette MSc, and C. van Walraven MD MSc Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis Can. Med. Assoc. J., July 29, 2008; 179(3): 235 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Almeida, A. Santos, F. Barreiros, M. Garcia, and P. Pinho Stuck leaflet of bileaflet prosthesis in mitral position - five cases to make us think Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 379 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Bryan, C. A. Rogers, K. Bayliss, J. Wild, and G. D. Angelini Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: Ten-year follow-up J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 614 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rizzoli, S. Mirone, P. Ius, E. Polesel, T. Bottio, L. Salvador, C. Zussa, G. Gerosa, and C. Valfre Fifteen-year results with the Hancock II valve: A multicenter experience. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 602 - 609.e4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Lund and M. Bland Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Butchart, C. Gohlke-Barwolf, M. J. Antunes, P. Tornos, R. De Caterina, B. Cormier, B. Prendergast, B. Iung, H. Bjornstad, C. Leport, et al. Recommendations for the management of patients after heart valve surgery Eur. Heart J., November 2, 2005; 26(22): 2463 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. De Santo, G. Romano, A. D. Corte, F. Tizzano, A. Petraio, C. Amarelli, M. De Feo, G. Dialetto, M. Scardone, and M. Cotrufo Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 13 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, C. Huth, and D. Horstkotte Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement: Results of the German Experience With Low-Intensity Anticoagulation Study Chest, January 1, 2005; 127(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rizzoli, I. Vendramin, G. Nesseris, T. Bottio, C. Guglielmi, and L. Schiavon Biological or mechanical prostheses in tricuspid position? a meta-analysis of intra-institutional results Ann. Thorac. Surg., May 1, 2004; 77(5): 1607 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, R. Gregorio, A. Renzulli, F. Onorati, M. De Feo, G. Grunkemeier, and M. Cotrufo Mechanical heart valves: Are two leaflets better than one? J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1171 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Shuhaiber, M. Massad, and A. Geha Study design in valve surgery and outcome J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1660 - 1661. [Full Text] [PDF]
|
|
|
|
|
|
D. Horstkotte Problems with complication rate analysis J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1668 - 1670. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
